Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats

Molecular and Cellular Neuroscience

Volumn 19, Issue 1, 2002, Pages 32-42

  O'Leary, M T ^a,b   Hinks, G L ^a   Charlton, H M ^b   Franklin, R J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; MESSENGER RNA; NT LACZ AD; SOMATOMEDIN C; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DEMYELINATION; DRUG DELIVERY SYSTEM; FEMALE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SCHWANN CELL; SPINE; VIRUS RECOMBINANT; WHITE MATTER;

ADENOVIRIDAE; ANIMALIA;

EID: 0036154986     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2001.1062     Document Type: Article

References (49)

1. Cell death and control of cell survival in the oligodendrocyte lineage
2. Remyelination of the superior cerebellar peduncle in old mice following demyelination induced by cuprizone
3. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS
4. Adenovirus gene transfer causes inflammation in the brain
5. Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination
6. Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination
7. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice
8. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions
9. Understanding CNS remyelination - Clues from developmental and regeneration biology
10. What roles do growth factors play in CNS remyelination?
11. Adenoviral vectors for in vivo gene delivery to oligodendrocytes: Transgene expression and cytopathic consequences
12. Endogenous progenitors remyelinate demyelinated axons in the adult CNS
13. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice
14. Protein growth factors as potential therapies for central nervous system demyelinative disorders
15. Insulin-like growth factors and binding proteins in multiple sclerosis plaques
16. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors
17. Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: Preferential survival of transduced astroglial cells in nude rats
18. Distinctive patterns of PDGF-A, FGF-2, IGF-I and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination
19. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats
20. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol
21. Response of oligodendrocyte progenitor cell population (defined by NG2 labeling) to demyelination of the adult spinal cord
22. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination
23. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination
24. Chronic relapsing experimental autoimmune encephalomyelitis: Effects of insulin-like growth factor-I treatment on clinical deficits, lesion severity, glial responses, and blood brain barrier defects
25. Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis
26. Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: Temporally distinct expression of midkine and pleiotrophin
27. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune allergic encephalomyelitis
28. An autoradiographic study of cellular proliferation in remyelination of the central nervous system
29. Mature oligodendrocyte apoptosis precedes IGF-I production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination
30. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination
31. A role for TGF-β in oligodendrocyte differentiation
32. Insulin-like growth factor I promotes proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro
33. Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease
34. Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures
35. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle
36. Gene therapy for spinal cord regeneration studies using first generation adenoviral vectors: Long term expression with minimal inflammation and tissue damage can be achieved using reduced viral titres in the low responder PVG rat strain
37. In vivo proliferation of oligodendrocyte progenitors expressing PDGF-αR during early remyelination
38. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts
39. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination
40. Developing oligodendroglia express mRNA for insulin-like growth factor-I, a regulator of oligodendrocyte development
41. The re-expression of the homeodomain transcription factor Gtx during remyelination of experimentally-induced demyelinating lesions in young and old rat brain
42. Functional analysis of the human IGF-I gene promoters
43. Widespread long-term gene transfer to mouse skeletal muscles and heart
44. Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: Immunohistochemical study
45. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells
46. Growth factors and remyelination in the CNS
47. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination
48. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis
49. Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration